The recent applications of nanotechnology in the diagnosis and treatment of common cardiovascular diseases

Vascul Pharmacol. 2023 Jul 25;152:107200. doi: 10.1016/j.vph.2023.107200. Online ahead of print.ABSTRACTAlmost a third of all fatalities may be attributed to cardiovascular disease (CVD), making it a primary cause of mortalities worldwide. Better diagnostic tools and secure, non-invasive imaging techniques are needed to offer accurate information on CVD progression. Several elements contribute to the success of CVD personalized therapy, and two of the most crucial are accurate diagnosis and early detection. The therapy options available for conditions with a pathogenesis that unfold over decades, such as CVD, are very condition-specific and disease-stage based. Nanotechnology is increasingly being used as a therapeutic tool in the biomedical area, where they are used in various contexts, including diagnostics, biosensing, and drug administration. This review article provides an overview of the most recent applications of nanotechnology in the detection and management of prevalent CVDs.PMID:37500029 | DOI:10.1016/j.vph.2023.107200
Source: Vascular Pharmacology - Category: Drugs & Pharmacology Authors: Source Type: research